| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72603-129-01 | 72603-129 | HUMAN PRESCRIPTION DRUG | Icosapent Ethyl | Icosapent Ethyl | CAPSULE | ORAL | 20220131 | N/A | ANDA | ANDA209457 | Northstar Rx LLC | ICOSAPENT ETHYL | 1 g/1 | 120 CAPSULE in 1 BOTTLE (72603-129-01) |
| 63629-9311-1 | 63629-9311 | HUMAN PRESCRIPTION DRUG | Icosapent Ethyl | Icosapent Ethyl | CAPSULE | ORAL | 20220706 | N/A | ANDA | ANDA209457 | Bryant Ranch Prepack | ICOSAPENT ETHYL | 1 g/1 | 120 CAPSULE in 1 BOTTLE (63629-9311-1) |
| 0054-0508-23 | 0054-0508 | HUMAN PRESCRIPTION DRUG | Icosapent Ethyl | Icosapent Ethyl | CAPSULE | ORAL | 20201104 | N/A | ANDA | ANDA209457 | Hikma Pharmaceuticals USA Inc. | ICOSAPENT ETHYL | 1 g/1 | 120 CAPSULE in 1 BOTTLE (0054-0508-23) |
| 0054-0621-27 | 0054-0621 | HUMAN PRESCRIPTION DRUG | Icosapent Ethyl | Icosapent Ethyl | CAPSULE | ORAL | 20230309 | N/A | ANDA | ANDA209457 | Hikma Pharmaceuticals USA Inc. | ICOSAPENT ETHYL | .5 g/1 | 240 CAPSULE in 1 BOTTLE (0054-0621-27) |